Clinical trialNCT07334119RecruitingPhase 1Interventional

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

SponsorMyeloid TherapeuticsEnrollment60HER2-Expressing Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Matthew Maurer, MD
Myeloid Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

the Kinghorn Cancer Centre
Darlinghurst, New South Wales, Australia
Dr Rasha Cosman
Recruiting
Scientia Clinical Research Ltd
Randwick, New South Wales, Australia
Dr Charlotte Lemech
Recruiting
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Dr Jordan Cohen
Recruiting
Icon Cancer Centre South Brisbane
South Brisbane, Queensland, Australia
A/Prof Jermaine Coward
Recruiting
Cancer Research Sa Pty Ltd
Adelaide, South Australia, Australia
Dr Meena Okera
Recruiting
Cabrini Health
Melbourne, Victoria, Australia
Dr. Prachi Bhave
Recruiting
Linear Clinical Research
Nedlands, Western Australia, Australia
Dr Timothy Humphries
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Nov 2025
Primary completion: 31 Jan 2027
Completion: 30 Mar 2028
Last update posted: 20 May 2026
Registered enrollment: 60
Registry id: NCT07334119

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.